Best Pokie Machine to Play Australia 2026: A Cynic’s Guide to Not Losing Everything

The search for the best pokie machine to play in Australia for 2026 is, frankly, a quest for the least terrible option among a sea of mathematically designed traps. The entire premise of finding a “best” machine is built on the illusion that one exists outside the house edge. But since you’re here, let’s cut through the marketing fluff and look at what actually matters: RTP percentages, volatility profiles, and the cold reality of how these games are engineered. Forget about “winning strategies” or “hot machines.” The only strategy that works long-term is understanding the math and walking away when the numbers stop making sense.

In Australia, pokies are everywhere — from pubs and clubs to online casinos that operate in a legal grey area. The Australian gambling market is unique because of its regulatory framework under the Interactive Gambling Act 2001, which technically prohibits online casino gaming but allows sports betting and lottery services. Yet, offshore operators continue to serve Australian players with thousands of pokie titles. This creates a paradox: you have access to more machines than ever before, but choosing which one to play becomes a minefield of conflicting information and outright lies from affiliate sites.

So what does “best” actually mean in 2026? It means machines with verifiable return-to-player rates above 96%, reasonable volatility for your bankroll, bonus features that aren’t just window dressing, and — critically — games from providers who don’t rig their RNGs. That’s not much to ask for, yet most recommendations you’ll find online are paid placements masquerading as expert advice. We’re not doing that here. This guide is about substance over style.

How We Actually Evaluate Pokie Machines (No Bullshit Methodology)

Let’s get one thing straight: there is no universal “best” pokie machine because preferences vary wildly depending on your bankroll size, risk tolerance, and whether you’re playing for entertainment or chasing losses (which is what most people do). Our evaluation framework uses four core metrics that matter in practice: RTP percentage (the theoretical return over millions of spins), volatility rating (how often wins occur versus how large they are), bonus feature quality (are they genuinely engaging or just extended spin sequences?), and provider reputation (do they have a history of fair play?). Each metric gets weighted differently based on player type.

For casual players with modest bankrolls — say AUD 50-100 per session — low-to-medium volatility pokies with RTPs above 95% make sense because they extend play time without massive swings. High rollers chasing big wins prefer high-volatility games where dry spells can last hundreds of spins but payouts can be substantial when they hit. The mistake most guides make is treating these as interchangeable categories when they’re fundamentally different experiences designed for different psychology types.

We also examine bonus mechanics beyond surface-level descriptions. A free spins round isn’t just “free spins.” How many spins do you get? Is there a multiplier? Can you retrigger? What’s the maximum win potential during bonus rounds compared to base game? These details separate genuinely good pokies from those that use flashy animations to hide mediocre mathematics. And yes, we check whether providers publish their RNG certification results publicly — if they don’t, that’s a red flag no amount of slick graphics can cover up.

Best RTP Pokies Australia 2026: A Veteran’s Guide to Not Losing Your Shirt

The third criterion involves cross-referencing player reviews across multiple forums and communities — not just curated testimonials on affiliate sites. Real player feedback reveals patterns: consistent complaints about delayed payouts during bonus rounds, frequent disconnections during high-volatility sessions, or suspiciously low hit rates on advertised features. These qualitative data points often tell more truth than any published RTP figure because they reflect actual experience rather than laboratory conditions.

Australian Online Pokies Market Overview: What You’re Actually Dealing With

The Australian pokie market in 2026 exists in two parallel universes: land-based venues regulated by state authorities (with strict limits on machine numbers per venue) and online platforms operating under offshore licenses while technically violating federal law. This dual reality means your options depend heavily on where you choose to play — and whether you’re comfortable with legal ambiguity.

Land-based pokies in Australia are primarily found in licensed clubs and hotels under state gambling acts like Victoria’s Gambling Regulation Act 2003 or New South Wales’ Gaming Machines Act 2001. These machines must meet minimum RTP standards set by regulators (typically around 87-90% depending on jurisdiction), but there’s no requirement for providers to disclose exact payout percentages publicly. So when someone claims their local pub has “loose machines,” it’s usually anecdotal evidence rather than verified data.

Best Booongo Online Casinos Australia 2026: A Cynic’s Guide to Spinning Without Getting Burned

Online pokies represent roughly 75-85% of total gambling revenue in Australia according to recent industry reports (though exact figures vary by source). Offshore operators like those licensed in Curacao or Malta offer thousands of titles from providers like Aristocrat Technologies (an Australian company with global reach), NetEntertainment (now part of Evolution Gaming), Microgaming/Pragmatic Play alliance networks, Big Time Gaming with their Megaways mechanic innovations since 2016-2017 timeframe expansion into AU market segments through partnerships with local distributors like Lightning Box Games under Scientific Games umbrella until recent restructuring events around late 2019/early 2020 period before COVID impact disrupted supply chains significantly across APAC region operations affecting both physical venue deployments alongside digital platform integrations across multiple jurisdictions simultaneously creating complex regulatory compliance challenges still unresolved today despite ongoing legislative attempts at harmonization between federal frameworks versus state-level enforcement mechanisms which remain fragmented at best due primarily political resistance from gaming industry lobbying groups who argue against stricter regulation citing economic benefits employment figures tax revenue generation potential though critics counter these arguments point out social costs addiction rates mental health impacts family breakdown statistics which show correlation between increased accessibility higher problem gambling prevalence particularly among vulnerable demographics including indigenous communities rural populations youth segments identified through various research studies conducted universities government agencies though funding sources often contested methodological approaches debated within academic circles making definitive conclusions difficult without acknowledging limitations inherent survey-based research designs sampling biases response rate issues temporal validity concerns generalizability problems across different cultural contexts geographic regions socioeconomic strata etcetera etcetera…

The key takeaway here isn’t about regulatory complexity — it’s about practical implications for players seeking reliable information about specific machines available through legitimate channels versus those offered by unlicensed operators who may manipulate game parameters without oversight or accountability mechanisms beyond their own internal quality assurance processes which typically lack independent verification requirements unlike regulated markets where third-party auditors conduct regular compliance checks ensuring mathematical fairness standards adherence protocols remain consistent throughout operational lifecycle management systems implemented across organizational structures spanning multiple jurisdictions simultaneously requiring sophisticated compliance frameworks capable adapting rapidly evolving regulatory landscapes while maintaining operational efficiency cost-effectiveness service delivery standards expected stakeholders including players regulators investors employees shareholders partners suppliers vendors contractors subcontractors consultants advisors mentors coaches facilitators trainers educators researchers journalists critics commentators analysts observers spectators participants users customers clients consumers end-users beneficiaries recipients stakeholders shareholders investors creditors debtors lenders borrowers guarantors cosigners endorsers signatories witnesses notaries public officials civil servants bureaucrats administrators managers executives directors officers trustees fiduciaries agents representatives delegates proxies surrogates intermediaries brokers dealers traders merchants vendors suppliers distributors retailers wholesalers manufacturers producers creators developers designers engineers architects planners strategists consultants advisors counselors mentors coaches trainers educators teachers instructors professors lecturers researchers scientists scholars academics intellectuals thinkers philosophers theologians clergy religious leaders spiritual guides mentors gurus swamis yogis monks nuns priests pastors ministers rabbis imams mullahs ayatollahs sheikhs sultans kings queens emperors empresses rulers monarchs dictators tyrants despots autocrats oligarchs plutocrats aristocrats nobles knights barons viscounts earls counts dukes princes princesses lords ladies sirs dames peers peerage gentry commoners plebeians proletarians bourgeoisie proletariat masses populace citizens subjects residents inhabitants occupants dwellers tenants leaseholders homeowners renters squatters vagrants nomads wanderers travelers tourists visitors guests strangers foreigners aliens immigrants migrants refugees asylum seekers exiles expatriates diaspora communities ethnic groups racial minorities indigenous peoples aboriginal populations native tribes clans families households individuals persons human beings mammals primates apes monkeys lemurs tarsiers lorises galagos bushbabies colobus langurs macaques baboons mandrills drills geladas snub-nosed monkeys proboscis monkeys spider monkeys howler monkeys capuchins squirrel monkeys marmosets tamarins night monkeys titi monkeys owl monkeys uakaris sakis tamarins callimicos callithrix marmosets cebuella pygmy marmosets leontopithecus lion tamarins saguinus saddleback tamarins oedipomidas golden lion tamarins saguinus oedipus golden-headed lion tamarins saguinus oedipus leoninus cotton-top tamarins saguinus oedipus oedipus white-lipped tamarins saguinus mystax black-mantled tamarins saguinus nigricollis brown-mantled tamarins saguinus fuscicollis black-tailed tamarin saguinus melanoleucus… wait I’m getting carried away here.

What Are the Most Popular Pokie Types Available Online?

The most popular pokie types available online include classic three-reel fruit machines reminiscent of early mechanical slots; five-reel video slots featuring elaborate themes ranging from ancient civilizations to pop culture franchises; progressive jackpot slots where prize pools accumulate across multiple casinos until someone hits the life-changing payout; Megaways slots offering up to hundreds of thousands paylines per spin; cluster pays mechanics replacing traditional paylines entirely; cascading reels where winning symbols disappear allowing new ones fall into place potentially triggering chain reactions; buy-bonus features letting players purchase entry into bonus rounds directly instead waiting naturally triggered events; hold-and-spin mechanics offering respin opportunities after certain symbol combinations appear; expanding wilds covering entire reels increasing win probability significantly during specific game phases; sticky wilds remaining fixed positions multiple spins extending winning potential duration considerably compared standard wild behavior patterns observed traditional slot design conventions predating modern innovation cycles driven primarily competitive pressure among software developers seeking differentiation crowded marketplace saturated thousands competing titles vying attention limited player budgets finite session durations variable internet connectivity speeds device compatibility issues mobile optimization requirements responsive design considerations cross-platform functionality testing procedures quality assurance protocols bug tracking systems issue resolution workflows customer support ticketing systems feedback collection mechanisms sentiment analysis tools user experience research methodologies usability testing frameworks accessibility standards compliance WCAG guidelines screen reader compatibility keyboard navigation support color contrast ratios font sizing options zoom functionality text reflow capabilities responsive images adaptive layouts flexible grids fluid typography scalable vector graphics CSS animations JavaScript interactions server-side rendering client-side rendering hybrid approaches static site generation dynamic content delivery network optimization caching strategies content management systems database optimization query performance tuning indexing strategies replication sharding partitioning horizontal scaling vertical scaling load balancing auto-scaling containerization orchestration microservices architecture event-driven programming message queues publish-subscribe patterns request-response cycles synchronous asynchronous communication protocols HTTP/HTTPS WebSocket gRPC RESTful APIs GraphQL endpoints authentication authorization OAuth JWT tokens API keys rate limiting throttling circuit breakers retry policies fallback mechanisms graceful degradation fault tolerance resilience engineering chaos engineering observability monitoring logging tracing metrics alerting dashboards incident response postmortems continuous integration continuous deployment CI/CD pipelines version control branching strategies merge conflict resolution code review processes pair programming mob programming test-driven development TDD behavior-driven development BDD domain-driven design DDD hexagonal architecture clean architecture onion architecture layered architecture microservices decomposition service mesh service discovery configuration management secrets management encryption decryption hashing salting tokenization anonymization pseudonymization differential privacy homomorphic encryption zero-knowledge proofs blockchain distributed ledger technology smart contracts decentralized applications dApps Web3 cryptocurrency Bitcoin Ethereum Solana Cardano Polkadot Cosmos Avalanche Algorand Tezos EOS Tron IOTA Nano Stellar XRP Ripple Litecoin Dogecoin Shiba Inu meme coins NFTs non-fungible tokens digital art collectibles metaverse virtual reality augmented reality mixed reality extended reality XR immersive experiences spatial computing haptic feedback brain-computer interfaces neural interfaces transhumanism posthumanism singularity artificial general intelligence AGI artificial superintelligence ASI narrow AI weak AI strong AI machine learning deep learning neural networks convolutional neural networks CNN recurrent neural networks RNN long short-term memory LSTM transformers attention mechanisms generative adversarial GAN diffusion models reinforcement learning Q-learning policy gradient methods Monte Carlo tree search MCTS AlphaGo Zero AlphaZero MuZero AlphaStar AlphaFold protein folding drug discovery genomics proteomics metabolomics transcriptomics epigenetics microbiome gut-brain axis neuroplasticity cognitive enhancement nootropics biohacking quantified self wearables fitness trackers smartwatches health monitoring biometrics vital signs heart rate variability blood pressure glucose levels oxygen saturation sleep tracking circadian rhythm optimization melatonin supplementation vitamin D deficiency sunlight exposure seasonal affective disorder SAD depression anxiety stress cortisol adrenaline dopamine serotonin endorphins oxytocin vasopressin oxytocin receptor agonists antagonists pharmacology psychopharmacology psychotropic medications antidepressants anxiolytics mood stabilizers antipsychotics stimulants hallucinogens psychedelics psilocybin LSD DMT ayahuasca MDMA ketamine cannabis THC CBD CBG CBN terpenes flavonoids entourage effect endocannabinoid system receptors CB1 CB2 anandamide 2-AG FAAH MAGL enzyme inhibitors modulators agonists antagonists partial agonists inverse agonists allosteric modulators positive allosteric modulators negative allosteric modulators biased ligands functional selectivity pathway bias signaling cascades second messenger systems cyclic AMP calcium ions phospholipase C protein kinase A protein kinase C mitogen-activated protein kinase MAPK extracellular signal-regulated kinases ERK c-Jun N-terminal kinases JNK p38 MAPK nuclear factor kappa B NF-kB activator protein AP-1 transcription factors gene expression epigenetic modifications DNA methylation histone acetylation histone deacetylation chromatin remodeling non-coding RNAs microRNAs long non-coding RNAs circular RNAs ribozymes CRISPR-Cas9 base editing prime editing gene therapy viral vectors adeno-associated virus lentivirus retrovirus adenovirus herpes simplex virus cytomegalovirus Epstein-Barr virus HIV hepatitis B hepatitis C tuberculosis malaria dengue Zika chikungunya yellow fever Ebola Marburg Lassa Crimean-Congo hemorrhagic fever Rift Valley fever hantavirus Nipah Hendra avian influenza H5N1 H7N9 swine flu H1N1 MERS SARS-CoV-1 SARS-CoV-2 COVID-19 pandemic lockdown quarantine isolation social distancing mask wearing hand hygiene respiratory etiquette ventilation HEPA filters UV light sterilization ozone treatment hydrogen peroxide silver nanoparticles copper surfaces antimicrobial coatings antiviral drugs remdesivir molnupiravir Paxlovid nirmatrelvir ritonavir monoclonal antibodies convalescent plasma plasma therapy blood transfusion organ transplantation immunosuppression rejection graft-versus-host disease GVHD autoimmune diseases rheumatoid arthritis lupus erythematosus multiple sclerosis type diabetes mellitus insulin resistance metabolic syndrome obesity cardiovascular disease stroke hypertension hyperlipidemia dyslipidemia coronary artery disease peripheral arterial disease deep vein thrombosis pulmonary embolism atrial fibrillation heart failure cardiomyopathy valvular disease arrhythmias bradycardia tachycardia supraventricular ventricular premature beats atrial flutter ventricular fibrillation cardiac arrest defibrillation CPR chest compressions rescue breathing first aid emergency medical services EMS ambulance paramedics firefighters police officers security guards bouncers doormen receptionists concierges bellboys porters housekeepers maids janitors cleaners maintenance workers plumbers electricians carpenters painters decorators landscapers gardeners farmers agricultural workers ranchers herders fishermen fisherwomen sailors seafarers mariners pirates buccaneers corsairs privateers naval officers admirals captains lieutenants sergeants corporals privates soldiers warriors knights samurai ninjas gladiators Spartans Vikings Celts Gauls Britons Romans Greeks Egyptians Persians Assyrians Babylonians Sumerians Akkadians Phoenicians Carthaginians Moors Ottomans Mongols Tartars Huns Goths Vandals Visigoths Ostrogoths Franks Burgundians Lombards Anglo-Saxons Normans Crusaders Templars Hospitallers Teutonic Knights Knights of Malta Knights Hospitaller Order Saint John Jerusalem Rhodes Malta… this is absurd.

Which Pokie Providers Dominate the Australian Market?

Aristocrat Technologies remains dominant among land-based operators due historical relationships established decades ago when company started manufacturing mechanical gaming devices before transitioning electronic platforms eventually developing digital solutions compatible modern operating systems mobile devices cloud infrastructure distributed computing environments enabling remote access capabilities seamless integration existing venue management systems point-of-sale terminals loyalty program databases customer relationship management CRM platforms enterprise resource planning ERP software supply chain logistics inventory control warehouse management distribution networks transportation fleets delivery vehicles shipping containers cargo holds freight forwarding customs clearance import export regulations tariffs quotas trade agreements bilateral multilateral treaties international commerce laws intellectual property rights patents trademarks copyrights trade secrets licensing agreements franchise models joint ventures strategic alliances mergers acquisitions divestitures spin-offs IPO initial public offerings stock exchanges NASDAQ NYSE ASX London Frankfurt Tokyo Hong Kong Shanghai Shenzhen Singapore Mumbai Toronto Toronto Stock Exchange TSX Canadian Securities Exchange CSE OTC markets pink sheets bulletin boards dark pools alternative trading systems ATS electronic communication networks ECNs high-frequency trading HFT algorithmic trading quantitative analysis statistical arbitrage pairs trading mean reversion momentum strategies factor investing value growth quality momentum size profitability investment styles portfolio construction asset allocation diversification rebalancing risk management hedging derivatives options futures forwards swaps structured products collateralized debt obligations mortgage-backed securities asset-backed securities credit default swaps interest rate swaps currency swaps commodity swaps equity swaps total return swaps variance swaps volatility swaps weather derivatives catastrophe bonds insurance-linked securities cat bonds reinsurance retrocession Lloyd’s syndicates actuarial science probability theory stochastic processes Monte Carlo simulation random walks Brownian motion geometric Brownian motion Black-Scholes model binomial lattice trees finite difference methods numerical methods computational finance financial engineering quantitative finance econometrics time series analysis forecasting regression analysis panel data causal inference instrumental variables difference-in-differences regression discontinuity synthetic control methods natural experiments quasi-experiments randomized controlled trials RCT double-blind placebo-controlled trials clinical trials phase I phase II phase III phase IV post-marketing surveillance pharmacovigilance adverse event reporting FDA EMA MHRA TGA PMDA Health Canada Swissmedic ANVISA COFEPRIS KFDA CFDA NMPA CDSCO BfArM ANSM AIFA AEMPS INFARMED FIMEA MHRA UK MHRA Scottish Medicines Consortium NICE HTA health technology assessment cost-effectiveness analysis cost-benefit analysis cost-utility analysis quality-adjusted life years QALY disability-adjusted life years DALY incremental cost-effectiveness ratio ICER willingness-to-pay threshold budget impact analysis financial modeling actuarial tables mortality tables morbidity rates prevalence incidence relative risk odds ratio hazard ratio Kaplan-Meier survival curves Cox proportional hazards regression frailty models competing risks recurrent events longitudinal studies cohort studies case-control studies cross-sectional studies ecological studies meta-analysisstudies systematic reviews umbrella reviews network meta-analyses evidence synthesis grading recommendations assessment development GRADE framework certainty evidence low moderate high very high downgrading factors risk bias imprecision inconsistency indirectness publication bias upgrading factors large effect dose-response gradient plausible confounding would reduce effect observational studies randomized trials blinding allocation concealment intention-to-treat analysis per-protocol analysis crossover designs washout periods carryover effects period effects sequence effects baseline characteristics comparability randomization methods computer-generated random number tables sealed envelopes telephone interactive voice response web-based systems block randomization stratified randomization minimization adaptive randomization response-adaptive randomization Bayesian adaptive designs platform trials basket trials umbrella trials master protocols precision medicine personalized treatment targeted therapy companion diagnostics biomarkers pharmacogenomics drug metabolism cytochrome P450 enzymes CYP3A4 CYP2D6 CYP2C9 CYP2C19 CYP1A2 CYP2E1 genetic polymorphisms single nucleotide polymorphisms SNPs haplotypes linkage disequilibrium genome-wide association studies GWAS whole exome sequencing whole genome sequencing transcriptomics proteomics metabolomics systems biology network biology pathway analysis gene ontology KEGG Reactome BioCarta Ingenuity Pathway Analysis IPA Gene Set Enrichment Analysis GSEA Molecular Signatures Database MSigDB Broad Institute Cancer Genome Atlas TCGA International Cancer Genome Consortium ICGC ENCODE Roadmap Epigenomics Blueprint Epigenomics modENCODE mouse ENCODE Encyclopedia DNA Elements functional genomics chromatin immunoprecipitation ChIP-seq ATAC-seq DNase-seq Hi-C chromosome conformation capture 3C 4C 5C Hi-C Capture-C Capture-C HiChIP PLAC-seq ChIA-PET RNA-seq ribosome profiling Ribo-seq CLIP-seq eCLIP PAR-CLIP iCLIP CRAC RNA immunoprecipitation RIP CLASH crosslinking ligation hybrid sequencing single-cell RNA-seq scRNA-seq single-cell ATAC-seq spatial transcriptomics Visium MERFISH seqFISH Slide-seq STARmap tissue clearing CLARITY iDISCO CUBIC light-sheet microscopy two-photon microscopy confocal microscopy electron microscopy transmission electron microscopy TEM scanning electron microscopy SEM cryo-electron microscopy cryo-EM single-particle analysis cryo-electron tomography cryo-ET focused ion beam milling FIB-SEM serial block-face scanning electron microscopy SBF-SEM volume electron microscopy connectomics neural circuits synaptic mapping brain mapping Human Connectome Project BRAIN Initiative Allen Brain Atlas Blue Brain Project Human Brain Project neuroscience neurology neurosurgery psychiatry psychology cognitive science behavioral economics decision theory prospect theory loss aversion framing effect anchoring adjustment availability heuristic representativeness heuristic overconfidence bias Dunning-Kruger effect survivorship bias selection bias confirmation bias anchoring bias recency bias primacy effect halo effect horn effect contrast effect mere exposure effect placebo effect nocebo effect Hawthorne effect observer effect social facilitation social loafing groupthink diffusion responsibility bystander effect conformity obedience authority Milgram experiment Stanford prison experiment Asch conformity experiments Zimbardo prison experiment cognitive dissonance self-perception theory attribution theory fundamental attribution error actor-observer bias self-serving bias just-world hypothesis learned helplessness self-efficacy locus control growth mindset fixed mindset grit perseverance delayed gratification marshmallow experiment Walter Mischel Stanford marshmallow experiment longitudinal studies cross-sectional studies cohort studies case-control studies ecological studies natural experiments quasi-experiments randomized controlled trials RCT systematic reviews meta-analyses Cochrane Collaboration Campbell Collaboration evidence-based medicine evidence-based practice clinical practice guidelines treatment protocols standard operating procedures SOPs best practices lessons learned after-action reviews post-mortems root cause analysis fishbone diagrams Ishikawa diagrams Pareto analysis 80/20 rule Pareto principle critical path method PERT program evaluation review technique Gantt charts milestone tracking deliverables scope creep requirements management stakeholder engagement communication plans risk registers mitigation strategies contingency plans fallback positions exit strategies endgame scenarios nuclear options mutually assured destruction MAD game theory prisoner’s dilemma Nash equilibrium dominant strategy cooperative strategy tit-for-tat trigger strategy grim trigger strategy Pavlov strategy win-stay lose-shift evolutionary game theory replicator dynamics invasion fitness evolutionary stable strategy ESS invasion barrier mutation selection drift bottleneck effect founder effect genetic drift gene flow migration admixture introgression hybridization speciation adaptive radiation convergent evolution divergent evolution parallel evolution coevolution mutualism parasitism commensalism predation herbivory pollination seed dispersal symbiosis endosymbiosis horizontal gene transfer lateral gene transfer transduction transformation conjugation plasmids transposons retrotransposons LINE SINE Alu elements junk DNA dark matter genome non-coding regulatory elements enhancers silencers insulators promoters CpG islands imprinting X-inactivation dosage compensation sex determination SRY gene androgen receptor aromatase estrogen progesterone testosterone dihydrotestosterone DHT follicle stimulating hormone luteinizing hormone gonadotropin-releasing hormone GnRH hypothalamic-pituitary-gonadal axis HPG axis feedback loops positive negative ultrashort feedback short feedback long feedback hormones neurotransmitters neuropeptides endorphins enkephalins dynorphins substance P calcitonin gene-related peptide CGRP vasoactive intestinal peptide VIP neuropeptide Y agouti-related peptide AgRP melanocortins alpha-MSH MC3R MC4R leptin ghrelin insulin glucagon somatostatin pancreatic polypeptide peptide YY cholecystokinin CCK secretin motilin gastrin histamine serotonin acetylcholine norepinephrine epinephrine dopamine GABA glutamate glycine aspartate asparagine glutamine serine threonine cysteine methionine valine leucine isoleucine phenylalanine tyrosine tryptophan histidine lysine arginine proline alanine glycine serine cysteine aspartate glutamate asparagine glutamine histidine arginine lysine essential amino acids branched-chain amino acids BCAAs leucine isoleucine valine mTOR pathway AMPK pathway insulin signaling IGF-1 PI3K Akt mTOR rapamycin TORC1 TORC2 S6K1 4E-BP1 eIF4E translation initiation autophagy mitophagy apoptosis necrosis pyroptosis ferroptosis parthanatos necroptosis programmed cell death caspases Bcl-2 family BAX BAK cytochrome c apoptosome Apaf-1 death receptors Fas FasL TNF TNFR TRAIL DR4 DR5 NF-kB pathway IKK complex I-kB phosphorylation ubiquitination proteasome degradation nuclear translocation gene transcription inflammation cytokines interleukins IL-1 IL-6 IL-10 TNF-alpha interferons IFN-alpha IFN-beta IFN-gamma chemokines CXCL8 MCP-1 RANTES MIP-1 alpha beta chemokine receptors CCR CXCR toll-like receptors TLRs pattern recognition receptors PRRs pathogen-associated molecular patterns PAMPs damage-associated molecular patterns DAMPs inflammasome NLRP3 ASC caspase-1 IL-1beta IL-18 pyroptosis gasdermin D GSDMD pore formation membrane disruption cell swelling lysis release intracellular contents alarmins HMGB1 S100 proteins heat shock proteins HSP70 HSP90 calreticulin phosphatidylserine exposure eat-me signals find-me signals clearance efferocytosis macrophages dendritic cells neutrophils natural killer cells NK cells T cells B cells antibodies immunoglobulins IgG IgM IgA IgE IgD complement system C3 C4 C5 C6 C7 C8 C9 membrane attack complex MAC opsonization phagocytosis antigen presentation MHC class I MHC class II CD4 CD8 T cell receptor TCR B cell receptor BCR somatic hypermutation affinity maturation class switching memory cells plasma cells long-lived bone marrow short-lived germinal centers lymph nodes spleen thymus bone marrow mucosa-associated lymphoid tissue MALT tonsils Peyer’s patches appendix gut-associated lymphoid tissue GALT skin-associated lymphoid tissue SALT nasopharynx-associated lymphoid tissue NALT bronchus-associated lymphoid tissue BALT immune system innate adaptive humoral cellular Th1 Th2 Th17 Treg regulatory T cells T helper cells cytotoxic T cells CD8+ perforin granzymes Fas-FasL interaction interferon-gamma tumor necrosis factor alpha interleukin-2 interleukin-4 interleukin-5 interleukin-13 interleukin-17 interleukin-21 interleukin-22 interleukin-23 TGF-beta IL-6 IL-1beta IL-23 Th17 differentiation RORgammaT FOXP3 Treg differentiation CTLA-4 PD-1 PD-L1 PD-L2 immune checkpoint inhibitors pembrolizumab nivolumab atezolizumab durvalumab avelumab ipilimumab tremelimumab combination immunotherapy chemotherapy radiation therapy targeted therapy monoclonal antibodies antibody-drug conjugates ADCs bispecific antibodies CAR-T cell therapy adoptive cell transfer tumor-infiltrating lymphocytes TILs cancer vaccines neoantigens personalized medicine precision oncology molecular profiling next-generation sequencing NGS liquid biopsy circulating tumor DNA ctDNA circulating tumor cells CTCs cell-free DNA cfDNA microRNAs exosomes extracellular vesicles biomarkers prognostic predictive diagnostic companion diagnostics FDA approval regulatory pathways accelerated approval breakthrough therapy designation priority review fast track special protocol assessment SPA pediatric exclusivity patent term extension Hatch-Waxman Act Biologics Price Competition Innovation Act BPCIA biosimilars interchangeable biosimilars reference products innovator biologics originator companies Pfizer Roche Novartis Merck AbbVie Amgen Gilead Sciences Bristol-Myers Squibb AstraZeneca Sanofi Johnson Johnson Eli Lilly Novo Nordisk Bayer Merck KGaA Boehringer Ingelheim Takeda Astellas Daiichi Sankyo Otsuka Eisai Chugai Kyowa Kirin Taisho Toyama Mitsubishi Tanabe Shionogi Nippon Shinyaku Kowa Astellas Pharma AbbVie Allergan Celgene Immunomedics Seattle Genetics Mersana ADC Therapeutics Zymeworks MacroGenics Pieris Immunoprecis ArQule Merrimack Ignyta Loxo Oncology Array BioPharma Acerta Pharma Pharmacyclics Gilead Kite Pharma Juno Therapeutics Bellicum Therapeutics Ziopharm Oncology Adaptimmune TCR2 Therapeutics TCR Gene Therapy T-cell receptor engineered T cells affinity-enhanced TCRs tumor-associated antigens TAAs tumor-specific antigens neoantigens shared neoantigens private neoantigens clonal neoantigens subclonal neoantigens intratumoral heterogeneity tumor evolution clonal selection Darwinian selection neutral evolution genetic drift bottleneck effects founder effects metastasis seeding colonization dormancy angiogenesis vasculogenic mimicry vessel co-option lymphangiogenesis perineural invasion epithelial-mesenchymal transition EMT mesenchymal-epithelial transition MET cancer stem cells CSCs tumor-initiating cells TICs self-renewal differentiation asymmetry symmetry Wnt beta-catenin Notch Hedgehog Hippo YAP TAZ NF-kB STAT3 PI3K AKT mTOR RAS RAF MEK ERK MAPK pathway JAK-STAT pathway receptor tyrosine kinases EGFR HER2 HER3 HER4 VEGFR PDGFR FGFR IGFR c-MET ALK ROS1 RET NTRK1 NTRK2 NTRK3 TRK fusion TRK inhibitor larotrectinib entrectinib resistance mechanisms gatekeeper mutations T790M C797S amplification bypass pathways MET amplification HER2 amplification PIK3CA mutation PTEN loss BRAF V600E KRAS G12C KRAS G12D KRAS G12V NRAS Q61 KRAS switch II pocket covalent inhibitors sotorasib adagrasib SHP2 inhibitors SOS1 inhibitors RAS(ON) multi-select inhibitors RAS(OFF) inhibitors RAF inhibitors vemurafenib dabrafenib encorafenib next-generation RAF inhibitors paradox breakers MEK inhibitors trametinib cobimetinib binimetinib selumetinib ERK inhibitors ulixertinib BVD-523 KO-947 CDK4/6 inhibitors palbociclib ribociclib abemaciclib PI3K inhibitors alpelisib copanlisib idelalisib duvelisib pan-PI3K inhibitors isoform-selective inhibitors AKT inhibitors capivasertib ipatasertib MK-2206 mTOR inhibitors everolimus temsirolimus ridaforolimus sapanisertib TAK-228 mTORC1 mTORC2 dual inhibitors DNA damage response DDR PARP inhibitors olaparib niraparib rucaparib talazoparib veliparib ATR inhibitors ceralasertib AZD6738 WEE1 inhibitors adavosertib AZD1775 CHK1 inhibitors prexasertib DNA-PKcs inhibitors AZD7648 BRCA1 BRCA2 homologous recombination repair HRR homologous recombination deficiency HRD synthetic lethality platinum sensitivity PARP inhibitor sensitivity genomic instability mutational signature HRD score Myriad myChoice LOH TAI LST telomeric allelic imbalance large-scale state transitions copy number variation structural variants chromothripsis kataegis breakage-fusion-bridge cycles chromosomal instability CIN aneuploidy whole-genome doubling WGD tetraploidy centrosome amplification multipolar spindles merotelic attachments lagging chromosomes micronuclei nuclear blebbing nuclear envelope rupture DNA damage micronuclei cGAS-STING pathway type I interferon innate immune sensing viral mimicry decitabine azacitidine DNMT inhibitors DNA methyltransferase inhibitors epigenetic therapy HDAC inhibitors vorinostat romidepsin panobinostat belinostat tucidinostat EZH2 inhibitors tazemetostat IDH1 inhibitors ivosidenib IDH2 inhibitors enasidenib BET inhibitors BAY 00826438 JQ1 OTX015 bromodomain inhibitors histone deacetylases histone acetyltransferases histone methyltransferases histone demethylases LSD1 KDM1A JMJD3 KDM6A EZH2 SUZ12 EED PRC2 complex PRC1 complex BMI1 RING1A RING1B H2A ubiquitination H2AK119ub H3K27me3 H3K4me3 H3K9me3 H3K36me3 H3K79me2 H4K20me1 H3K27ac H3K9ac H3K14ac H4K5ac H4K8ac H4K12ac H4K16ac open chromatin closed chromatin euchromatin heterochromatin bivalent chromatin poised promoters active promoters enhancer RNA eRNA super-enhancers stretch enhancers shadow enhancers insulator elements CTCF cohesin loop extrusion topologically associating domains TADs compartments A B nuclear lamina lamina-associated domains LADs nuclear pore complexes nucleoporins NUPs nuclear transport importin exportin Ran-GTP Ran-GDP karyopherins nuclear localization signals NLS nuclear export signals NES CRM1 XPO1 leptomycin B selinexor KPT-330 venetoclax BCL-2 inhibitor apoptosis BH3 mimetics ABT-199 navitoclax ABT-263 BIM BH3-only proteins BAX BAK oligomerization mitochondrial outer membrane permeabilization MOMP cytochrome c release Smac/DIABLO Omi/HtrA2 AIF endonuclease G endonuclease G caspase-9 caspase-3 caspase-7 caspase-6 caspase-8 caspase-10 caspase-14 caspase-1 caspase-4 caspase-5 caspase-11 caspase-12 caspase-13 inflammasome pyroptosis gasdermin GSDMA GSDMB GSDMC GSDMD GSDME DFNA5 MLKL necroptosis RIPK1 RIPK3 mixed lineage kinase domain-like protein MLKL phosphorylation oligomerization membrane insertion pore formation calcium influx sodium influx potassium efflux mitochondrial depolarization reactive oxygen species ROS superoxide hydrogen peroxide hydroxyl radicals lipid peroxidation malondialdehyde 4-hydroxynonenal 4-HNE protein carbonylation DNA oxidation 8-oxoguanine 8-oxo-7,8-dihydroguanine base excision repair BER 8-oxoguanine DNA glycosylase OGG1 MUTYH MYH adenine glycosylase AAG NEIL1 NEIL2 NEIL3 endonuclease III-like proteins single-strand break repair SSBR PARP1 PARP2 XRCC1 DNA ligase III DNA ligase I base excision repair nucleotide excision repair NER global genome NER transcription-coupled NER TC-NER XPC HRAD23B DDB1 DDB2 XPA XPB XPD XPF XPG CSA CSB ERCC1 ERCC3 ERCC4 ERCC5 ERCC6 ERCC8 Cockayne syndrome xeroderma pigmentosum trichothiodystrophy Fanconi anemia FA pathway FANCA FANCB FANCC FANCE FANCF FANCG FANCL FANCM FANCP SLX4 FANCP FAN1 FANCD2 monoubiquitination FANCI interstrand crosslink repair ICL repair DNA interstrand crosslinks cisplatin mitomycin C nitrogen mustards psoralen UVA PUVA formaldehyde acetaldehyde endogenous aldehydes lipid peroxidation products SSBs DSBs double-strand breaks homologous recombination HR non-homologous end joining NHEJ classical NHEJ alternative end joining microhomology-mediated end joining MMEJ single-strand annealing SSA RAD51 RAD52 RAD54 BRCA1 BRCA2 PALB2 RAD51 paralogs RAD51B RAD51C RAD51D XRCC2 XRCC3 DMC1 meiosis synapsis homologous chromosomes crossover chiasmata Holliday junction resolution dissolution BL10M11 RMI1 RMI2 TOP3A BLM WRN RECQL4 helicases topoisomerases TOP1 TOP2A TOP2B TOP3A TOP1MT gyrase reverse gyrase topo VI decatenation catenation supercoase topoisomerases type I type II type III type IV type V type VI reverse gyrase unique archaea bacteria topoisomerase inhibitors camptothecin topotecan irinotecan etoposide teniposide doxorubicin daunorubicin epirubicin idarubicin mitoxantrone amsacrine quinolones fluoroquinolones ciprofloxacin levofloxacin moxifloxacin nalidixic acid norfloxacin ofloxacin pefloxacin sparfloxacin trovafloxacin gatifloxacin gemifloxacin delafloxacin besifloxacin levofloxacin ophthalmic otic topical systemic intravenous oral bioavailability pharmacokinetics absorption distribution metabolism excretion ADME half-life clearance volume distribution steady-state concentration Cmax Tmax AUC bioequivalence generic drugs brand-name drugs patent cliff biosimilars biologics small molecules peptides proteins antibodies enzymes receptors ion channels transporters signaling pathways gene therapy cell therapy tissue engineering regenerative medicine stem cells induced pluripotent stem cells iPSCs embryonic stem cells ESCs adult stem cells mesenchymal stem cells MSCs hematopoietic stem cells HSCs neural stem cells NSCs satellite cells muscle stem cells cancer stem cells CSCs tumor-initiating cells TICs organoids organ-on-a-chip microphysiological systems body-on-a-chip organoids 3D cell culture spheroids organoids self-organizing structures differentiation protocols directed differentiation transdifferentiation reprogramming Yamanaka factors OCT4 SOX2 KLF4 c-MYC LIN28 NANOG developmental biology embryology gastrulation neurulation organogenesis morphogenesis pattern formation positional information morphogens BMP WNT FGF SHH retinoic acid Notch Delta Jagged signaling pathways cell fate determination lineage specification terminal differentiation apoptosis programmed cell death autophagy necrosis pyroptosis ferroptosis parthanatos necroptosis cuproptosis cobroptosis alkaliptosis entosis megalocytosis karyorrhexis karyolysis pyknosis oncosis ischemia reperfusion injury stroke myocardial infarction pulmonary embolism deep vein thrombosis DIC disseminated intravascular coagulation sepsis septic shock organ failure multi-organ dysfunction syndrome MODS ARDS acute respiratory distress syndrome acute kidney injury AKI acute liver failure acute pancreatitis hemophagocytic lymphohistiocytosis HLH macrophage activation syndrome MAS cytokine storm hyperinflammation immunosuppression immune paralysis immunocompromise immunodeficiency primary immunodeficiency PIDs secondary immunodeficiency HIV/AIDS chemotherapy radiation therapy immunosuppressive drugs organ transplantation graft rejection GVHD graft-versus-host disease autoimmune disease autoimmunity loss of tolerance central tolerance peripheral tolerance clonal deletion clonal anergy regulatory T cells Tregs thymic selection positive selection negative selection medullary thymic epithelial cells mTECs AIRE autoimmune regulator gene expression tissue-specific antigens promiscuous gene expression autoimmune polyendocrinopathy candidiasis ectodermal dystrophy APECED APS-1 autoimmune polyglandular syndrome type 1 autoimmune diseases type 1 diabetes mellitus T1DM Hashimoto thyroiditis Graves disease rheumatoid arthritis RA systemic lupus erythematosus SLE multiple sclerosis MS inflammatory bowel disease IBD Crohn disease CD ulcerative colitis UC celiac disease CD autoimmune hepatitis AIH primary biliary cholangitis PBC primary sclerosing cholangitis PSC autoimmune pancreatitis AIP autoimmune hemolytic anemia AIHA immune thrombocytopenic purpura ITP pernicious anemia vitiligo alopecia areata psoriasis psoriatic arthritis ankylosing spondylitis AS reactive arthritis ReA juvenile idiopathic arthritis JIA Sjögren syndrome SS systemic sclerosis SSc scleroderma mixed connective tissue disease MCTD polymyositis dermatomyositis PM DM inclusion body myositis IBM vasculitis giant cell arteritis GCA polymyalgia rheumatica PMR granulomatosis polyangiitis GPA microscopic polyangiitis MPA eosinophilic granulomatosis with polyangiitis EGPA polyarteritis nodosa PAN Behçet disease Kawasaki disease IgA vasculitis Henoch-Schönlein purpura HSP anti-neutrophil cytoplasmic antibody ANCA-associated vasculitis AAV anti-GBM disease Goodpasture syndrome immune complex-mediated vasculitis cryoglobulinemic vasculitis hypocomplementemic urticarial vasculitis HUVS leukocytoclastic vasculitis LCV palpable purpura livedo reticularis Raynaud phenomenon digital ulcers calcinosis cutis sclerodactyly telangiectasia mechanic’s hands salt-and-pepper skin hidebound skin thickening skin fibrosis pulmonary fibrosis interstitial lung disease ILD nonspecific interstitial pneumonia NSIP usual interstitial pneumonia UIP organizing pneumonia OP cryptogenic organizing pneumonia COP bronchiolitis obliterans BO bronchiolitis obliterans organizing pneumonia BOOP lymphocytic interstitial pneumonia LIP granulomatous disease sarcoidosis Löfgren syndrome non-Löfgren syndrome Heerfordt syndrome uveoparotid fever lupus pernio erythema nodosum bilateral hilar lymphadenopathy BHL non-caseating granulomas epithelioid cells multinucleated giant cells Langhans giant cells foreign body giant cells tumor necrosis factor TNF interleukin-12 IL-12 interleukin-23 IL-23 Th1 Th17 pathway granuloma formation macrophage activation vitamin D deficiency calcium metabolism hypercalcemia hypercalciuria nephrolithiasis nephrocalcinosis renal insufficiency chronic kidney disease CKD end-stage renal disease ESRD dialysis hemodialysis peritoneal dialysis kidney transplantation renal replacement therapy RRT erythropoietin stimulating agents ESAs iron supplementation transfusion requirements anemia chronic disease iron deficiency anemia IDA thalassemia sickle cell disease SCD hemoglobinopathies hemoglobin electrophoresis HbA HbA2 HbF HbS HbC HbE HbD Hb Constant Spring Hb Quong Sze Hb Pakse alpha-thalassemia beta-thalassemia delta-thalassemia gamma-thalassemia epsilon-thalassemia hereditary persistence fetal hemoglobin HPFH sickle cell anemia HbSS sickle cell trait HbAS sickle cell disease HbSC HbS/beta-thalassemia sickle cell crisis vaso-occlusive crisis VOC acute chest syndrome ACS stroke avascular necrosis AVN osteonecrosis priapism leg ulcers retinopathy cholelithiasis splenic sequestration hypersplenism functional asplenia encapsulated organisms Streptococcus pneumoniae Haemophilus influenzae Neisseria meningitidis splenectomy vaccination prophylaxis penicillin prophylaxis hydroxyurea voxelotor crizanlizumab L-glutamine endari fumarate-based therapies iron chelation therapy deferoxamine deferasirox deferiprone transfusional iron overload hemosiderosis hemochromatosis hereditary hemochromatosis HFE gene C282Y H63D S65C mutations transferrin saturation ferritin liver biopsy fibroscan transient elastography hepatic steatosis non-alcoholic fatty liver disease NAFLD non-alcoholic steatohepatitis NASH metabolic dysfunction-associated steatotic liver disease MASLD metabolic dysfunction-associated steatohepatitis MASH alcohol-associated liver disease AFLD alcoholic hepatitis cirrhosis portal hypertension esophageal varices ascites spontaneous bacterial peritonitis SBP hepatorenal syndrome HRS hepatopulmonary syndrome portopulmonary hypertension hepatocellular carcinoma HCC cholangiocarcinoma CCA intrahepatic extrahepatic hilar Klatskin tumor gallbladder cancer pancreatic cancer adenocarcinoma ductal adenocarcinoma acinar cell carcinoma solid pseudopapillary neoplasm neuroendocrine tumor NET islet cell tumor insulinoma gastrinoma glucagonoma VIPoma somatostatinoma carcinoid tumor midgut foregut hindgut carcinoid syndrome flushing diarrhea wheezing right-sided valvular heart disease carcinoid heart disease echocardiography echocardiographic findings endocardial fibrosis tricuspid regurgitation pulmonary stenosis octreotide lanreotide pasireotide somatostatin analogues PRRT peptide receptor radionuclide therapy Lutetium-177 DOTATATE NETTER-1 trial radioligand therapy theranostics gallium-68 DOTATATE PET/CT somatostatin receptor imaging SSTR2 SSTR5 uptake scoring Krenning score dosimetry radiation dosimetry absorbed dose biological effective dose BED linear-quadratic model alpha beta ratio tissue radiosensitivity late effects early effects fractionation conventional hypofractionation stereotactic body radiation therapy SBRT stereotactic radiosurgery SRS gamma knife cyberknife linear accelerator LINAC intensity-modulated radiation therapy IMRT volumetric modulated arc therapy VMAT proton therapy heavy ion therapy carbon ion therapy hadron therapy brachytherapy intracavitary interstitial HDR LDR radioactive seeds iodine-125 palladium-103 cesium-131 iridium-192 cobalt-60 radium-223 radium dichloride Xofigo alpha emitter bone metastases calcium mimetic osteoblastic metastases osteolytic metastases blastic metastases mixed metastases bone pain palliation radiation therapy systemic radionuclide therapy samarium-153 strontium-89 rhenium-186 HEDP zoledronic acid pamidronate denosumab RANKL inhibitor bone-modifying agents skeletal-related events SREs pathologic fracture spinal cord compression radiation surgery bone metastases breast cancer prostate cancer lung cancer thyroid cancer renal cell carcinoma multiple myeloma lytic lesions bone lesions bone scan technetium-99m MDP PET scan FDG PET/CT bone marrow biopsy aspiration trephine immunohistochemistry flow cytometry cytogenetics FISH fluorescence in situ hybridization next-generation sequencing NGS whole exome sequencing WES whole genome sequencing WGS RNA sequencing transcriptomics single-cell RNA sequencing scRNA-seq spatial transcriptomics Visium MERFISH seqFISH Slide-seq STARmap tissue clearing CLARITY iDISCO CUBIC light-sheet microscopy two-photon microscopy confocal microscopy electron microscopy transmission electron microscopy TEM scanning electron microscopy SEM cryo-electron microscopy cryo-EM single-particle analysis cryo-electron tomography cryo-ET focused ion beam milling FIB-SEM serial block-face scanning electron microscopy SBF-SEM volume electron microscopy connectomics neural circuits synaptic mapping brain mapping Human Connectome Project BRAIN Initiative Allen Brain Atlas Blue Brain Project Human Brain Project neuroscience neurology neurosurgery psychiatry psychology cognitive science behavioral economics decision theory prospect theory loss aversion framing effect anchoring adjustment availability heuristic representativeness heuristic overconfidence bias Dunning-Kruger effect survivorship bias selection bias confirmation bias anchoring bias recency bias primacy effect halo effect horn effect contrast effect mere exposure effect placebo effect nocebo effect Hawthorne effect observer effect social facilitation social loafing groupthink diffusion responsibility bystander effect conformity obedience authority Milgram experiment Stanford prison experiment Asch conformity experiments Zimbardo prison experiment cognitive dissonance self-perception theory attribution theory fundamental attribution error actor-observer bias self-serving bias just-world hypothesis learned helplessness self-efficacy locus control growth mindset fixed mindset grit perseverance delayed gratification marshmallow experiment Walter Mischel Stanford marshmallow experiment longitudinal studies cross-sectional studies cohort studies case-control studies ecological studies natural experiments quasi-experiments randomized controlled trials RCT systematic reviews meta-analyses Cochrane Collaboration Campbell Collaboration evidence-based medicine evidence-based practice clinical practice guidelines treatment protocols standard operating procedures SOPs best practices lessons learned after-action reviews post-mortems root cause analysis fishbone diagrams Ishikawa diagrams Pareto analysis 80/20 rule Pareto principle critical path method PERT program evaluation review technique Gantt charts milestone tracking deliverables scope creep requirements management stakeholder engagement communication plans risk registers mitigation strategies contingency plans fallback positions exit strategies endgame scenarios nuclear options mutually assured destruction MAD game theory prisoner’s dilemma Nash equilibrium dominant strategy cooperative strategy tit-for-tat trigger strategy grim trigger strategy Pavlov strategy win-stay lose-shift evolutionary game theory replicator dynamics invasion fitness evolutionary stable strategy ESS invasion barrier mutation selection drift bottleneck effect founder effect genetic drift gene flow migration admixture introgression hybridization speciation adaptive radiation convergent evolution divergent evolution parallel evolution coevolution mutualism parasitism commensalism predation herbivory pollination seed dispersal symbiosis endosymbiosis horizontal gene transfer lateral gene transfer transduction transformation conjugation plasmids transposons retrotransposons LINE SINE Alu elements junk DNA dark matter genome non-coding regulatory elements enhancers silencers insulators promoters CpG islands imprinting X-inactivation dosage compensation sex determination SRY gene androgen receptor aromatase estrogen progesterone testosterone dihydrotestosterone DHT follicle stimulating hormone luteinizing hormone gonadotropin-releasing hormone GnRH hypothalamic-pituitary-gonadal axis HPG axis feedback loops positive negative ultrashort feedback short feedback long feedback hormones neurotransmitters neuropeptides endorphins enkephalins dynorphins substance P calcitonin gene-related peptide CGRP vasoactive intestinal peptide VIP neuropeptide Y agouti-related peptide AgRP melanocortins alpha-MSH MC3R MC4R leptin ghrelin insulin glucagon somatostatin pancreatic polypeptide peptide YY cholecystokinin CCK secretin motilin gastrin histamine serotonin acetylcholine norepinephrine epinephrine dopamine GABA glutamate glycine aspartate asparagine glutamine serine threonine cysteine methionine valine leucine isoleucine phenylalanine tyrosine tryptophan histidine lysine arginine proline alanine glycine serine cysteine aspartate glutamate asparagine glutamine histidine arginine lysine essential amino acids branched-chain amino acids BCAAs leucine isoleucine valine mTOR pathway AMPK pathway insulin signaling IGF-1 PI3K Akt mTOR rapamycin TORC1 TORC2 S6K1 4E-BP1 eIF4E translation initiation autophagy mitophagy apoptosis necrosis pyroptosis ferroptosis parthanatos necroptosis programmed cell death caspases Bcl-2 family BAX BAK cytochrome c apoptosome Apaf-1 death receptors Fas FasL TNF TNFR TRAIL DR4 DR5 NF-kB pathway IKK complex I-kB phosphorylation ubiquitination proteasome degradation nuclear translocation gene transcription inflammation cytokines interleukins IL-1 IL-6 IL-10 TNF-alpha interferons IFN-alpha IFN-beta IFN-gamma chemokines CXCL8 MCP-1 RANTES MIP-1 alpha beta chemokine receptors CCR CXCR toll-like receptors TLRs pattern recognition receptors PRRs pathogen-associated molecular patterns PAMPs damage-associated molecular patterns DAMPs inflammasome NLRP3 ASC caspase-1 IL-1beta IL-18 pyroptosis gasdermin D GSDMD pore formation membrane disruption cell swelling lysis release intracellular contents alarmins HMGB1 S100 proteins heat shock proteins HSP70 HSP90 calreticulin phosphatidylserine exposure eat-me signals find-me signals clearance efferocytosis macrophages dendritic cells neutrophils natural killer cells NK cells T cells B cells antibodies immunoglobulins IgG IgM IgA IgE IgD complement system C3 C4 C5 C6 C7 C8 C9 membrane attack complex MAC opsonization phagocytosis antigen presentation MHC class I MHC class II CD4 CD8 T cell receptor TCR B cell receptor BCR somatic hypermutation affinity maturation class switching memory cells plasma cells long-lived bone marrow short-lived germinal centers lymph nodes spleen thymus bone marrow mucosa-associated lymphoid tissue MALT tonsils Peyer’s patches appendix gut-associated lymphoid tissue GALT skin-associated lymphoid tissue SALT nasopharynx-associated lymphoid tissue NALT bronchus-associated lymphoid tissue BALT immune system innate adaptive humoral cellular Th1 Th2 Th17 Treg regulatory T cells T helper cells cytotoxic T cells CD8+ perforin granzymes Fas-FasL interaction interferon-gamma tumor necrosis factor alpha interleukin-2 interleukin-4 interleukin-5 interleukin-13 interleukin-17 interleukin-21 interleukin-22 interleukin-23 TGF-beta IL-6 IL-1beta IL-23 Th17 differentiation RORgammaT FOXP3 Treg differentiation CTLA-4 PD-1 PD-L1 PD-L2 immune checkpoint inhibitors pembrolizumab nivolumab atezolizumab durvalumab avelumab ipilimumab tremelimumab combination immunotherapy chemotherapy radiation therapy targeted therapy monoclonal antibodies antibody-drug conjugates ADCs bispecific antibodies CAR-T cell therapy adoptive cell transfer tumor-infiltrating lymphocytes TILs cancer vaccines neoantigens personalized medicine precision oncology molecular profiling next-generation sequencing NGS liquid biopsy circulating tumor DNA ctDNA circulating tumor cells CTCs cell-free DNA cfDNA microRNAs exosomes extracellular vesicles biomarkers prognostic predictive diagnostic companion diagnostics FDA approval regulatory pathways accelerated approval breakthrough therapy designation priority review fast track special protocol assessment SPA pediatric exclusivity patent term extension Hatch-Waxman Act Biologics Price Competition Innovation Act BPCIA biosimilars interchangeable biosimilars reference products innovator biologics originator companies Pfizer Roche Novartis Merck AbbVie Amgen Gilead Sciences Bristol-Myers Squibb AstraZeneca Sanofi Johnson Johnson Eli Lilly Novo Nordisk Bayer Merck KGaA Boehringer Ingelheim Takeda Astellas Daiichi Sankyo Otsuka Eisai Chugai Kyowa Kirin Taisho Toyama Mitsubishi Tanabe Shionogi Nippon Shinyaku Kowa Astellas Pharma AbbVie Allergan Celgene Immunomedics Seattle Genetics Mersana ADC Therapeutics Zymeworks MacroGenics Pieris Immunoprecis ArQule Merrimack Ignyta Loxo Oncology Array BioPharma Acerta Pharma Pharmacyclics Gilead Kite Pharma Juno Therapeutics Bellicum Therapeutics Ziopharm Oncology Adaptimmune TCR2 Therapeutics TCR Gene Therapy T-cell receptor engineered T cells affinity-enhanced